Effect of a Multi-strain Probiotic Formulation on Immune Response to Influenza Vaccination
Clinical trial NCT05157425 · COMPLETED
Trial details
- NCT number
- NCT05157425
- Sponsor
- AB Biotics, SA
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-26
- Primary completion
- 2022-02-28
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.